Deutsche Bank Downgrades BRKR To Hold

Deutsche Bank has issued a report downgrading Bruker Corp. BRKR from Buy to Hold. According to Deutsche Bank, “We now see limited EPS upside vs. our FY11 forecast of $1.00 (above mgmt. guidance of $0.90-0.93) given tough stimulus comps and anemic outlook for government/academic research budgets. Given fair risk-reward at current valuation level, we are downgrading BRKR from Buy to Hold.” BRKR has a $23 Price Target and closed yesterday at $21.22 a share.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesAnalyst RatingsDeutsche BankHealth CareLife Sciences Tools & Services
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!